Form 4: Praxis Precision Medicines CFO Acquires Shares Through Employee Stock Purchase Plan
SEC Form 4 Filing
Praxis Precision Medicines' Chief Financial Officer, Timothy Edwin Kelly, acquired 205 shares of common stock through the company's Employee Stock Purchase Plan.
Summary
- Timothy Edwin Kelly, the Chief Financial Officer of Praxis Precision Medicines, Inc., acquired 205 shares of common stock on November 14, 2024.
- The shares were purchased at a price of $37.4 each.
- The transaction was made through the company's Employee Stock Purchase Plan.
- Following the transaction, Mr. Kelly directly owns 12,345 shares of Praxis Precision Medicines stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction, indicating a positive but not overly significant sentiment. The CFO's participation in the ESPP is a positive sign, but the transaction itself is not a major event.
Positives
- The CFO's participation in the Employee Stock Purchase Plan demonstrates confidence in the company's future.
- The acquisition increases the CFO's stake in the company, aligning his interests with those of shareholders.
Industry Context
This is a routine transaction for a company with an employee stock purchase plan, and is common for executives to participate in these plans.
Comparison to Industry Standards
- Employee stock purchase plans are a common practice in publicly traded companies, particularly in the biotech and pharmaceutical sectors.
- Executive participation in these plans is generally viewed positively by investors as it aligns management's interests with those of shareholders.
- The number of shares acquired is relatively small compared to the total outstanding shares of the company, and is not unusual for an executive's participation in an ESPP.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it demonstrates management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 11/14/2024 | Date of the stock acquisition by Timothy Edwin Kelly. |
| 11/19/2024 | Date the Form 4 was signed by Alex Nemiroff, as Attorney-in-Fact. |
Keywords
Praxis Precision Medicines, Employee Stock Purchase Plan, insider trading, share acquisition, Timothy Edwin Kelly, CFO, stock ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.